APP Pharmaceuticals Launches Rocuronium Bromide Injection (Medical News Today) Print

APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon's Zemuron®.

read more